期刊文献+

妊娠滋养细胞肿瘤肺转移患者的疗效分析 被引量:2

The analysis on efficacy of patients of gestational trophoblastic neoplasia with pulmonary metastases
原文传递
导出
摘要 目的评价妊娠滋养细胞肿瘤(gestational trophoblastic neoplasia,GTN)肺转移患者的治疗效果。方法对2000年1月至2012年1月郑州大学第一附属医院妇产科收治的妊娠滋养细胞肿瘤肺转移患者179例进行回顾性分析,将患者分为初诊组73例、耐药组69例和复发组37例,对其血清β-绒毛膜促性腺激素(human chorionic,gonadotropin,hCG)值和肺部转移灶情况进行对比分析。结果初诊组的完全缓解率、完全缓解平均所需化疗疗程及复发率明显优于耐药组和复发组(P<0.05);耐药组和复发组中血β-hCG正常但肺部转移灶未消失患者的病情进展率明显高于初诊组(P<0.05)。结论初诊肺转移患者经规范化疗后完全治愈率高,血β-hCG正常肺部转移灶未消失的情况下,复发和耐药患者病情稳定性相对较差,而初诊组肺部转移灶多可自行消失。既往出现耐药的复发患者再次治疗的效果较差,需进一步探讨有效可行的治疗方法。 Objective To investigate the treatment of efficacy of patients of gestational trophoblastic neoplasia (GTN)with pulmonary metastases. Methods A retrospective analysis of 179 GTN patients with pulmonary metastases in The First Affiliated Hospital of Zhengzhou University during January 2000 to January 2012 was carried out. The cases were divided into first - diagnosed group(73 cases),drug - resist group(69 cases)and recurrent group(37 cases). The β - human chorionic gonadotrophin( hCG)titer and pulmonary lesion( s)were compared statistically between the three groups. Results The complete remission rates,the average course of chemotherapy and recurrence rate in first - diagnosed group were prior to the other two groups(P〈 0. 05). The disease progress rate of patients whose β - hCG were normal but pulmonary metastases were still exist in drug - resist group and recurrent group were significantly higher than first - diagnosed group( P〈 0. 05). Conclusion The first - diagnosed GTN patients with pulmonary metastases have a high completely cure rate after standardized chemotherapy. When the β -hCG is normal but pulmonary metastases are still exist,recurrent and drug - resistant patients have poor outcomes, while the first - diagnosed patients have a high rate of pulmonary metastases disappearing. The recurrent drug -resistant patients have poor outcomes in retreatment,whose treatment need further discuss.
出处 《中国计划生育和妇产科》 2014年第4期29-32,共4页 Chinese Journal of Family Planning & Gynecotokology
关键词 妊娠滋养细胞肿瘤 肺转移 复发 耐药 gestational trophoblastic neoplasia pulmonary metastases recurrent drug - resistant
  • 相关文献

参考文献7

二级参考文献23

  • 1万希润,向阳,杨秀玉,吴郁,刘宁,陈玲,董若凡.FAEV化疗方案治疗高危型耐药性妊娠滋养细胞肿瘤的疗效分析[J].中华妇产科杂志,2006,41(2):88-90. 被引量:11
  • 2贺豪杰,向阳,万希润,冯凤芝,杨秀玉.双胎之一葡萄胎妊娠合并肺转移继发呼吸功能衰竭的诊断和处理[J].现代妇产科进展,2006,15(7):545-546. 被引量:7
  • 3杨隽钧,向阳,万希润,杨秀玉.妊娠滋养细胞肿瘤Ⅳ期患者的治疗和预后分析[J].中华妇产科杂志,2006,41(10):693-696. 被引量:5
  • 4Yang J, Xiang Y, Wan X, et al. The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment. Gynecol Oncol,2006,103:479-482.
  • 5Powles T, Savage P, Short D, et al. Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia : should we operate? Br J Cancer,2006,94:51-54.
  • 6Jones WB, Romain K, Erlandson RA, et al. Thoracotomy in the management of gestational choriocarcinoma. A clinicopathologic study. Cancer, 1993,72:2175-2181.
  • 7Tomoda Y,Arii Y,Kaseki S,et al.Surgical indications for resection in pulmonary metastasis of choriocarcinoma[J].Cancer,1980,46(12):2723-2730.
  • 8Fleming EL,Garrett L,Growdon WB,et al.The changing role of thoracotomy in gestational trophoblatic neoplasia at the New England Trophoblastic Disease Center[J].J Report Med,2008,53(7):493-498.
  • 9Newlands ES,Mulholland PJ,Holden L,et al.Etoposide and cisplatin/etoposide,methotrexate,and actinomycin D(EMA)chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors[J].J Clin Oncol,2000,18(4):854-859.
  • 10El-Helw LM,Hancock BW.Treatment of metastatic gestational trophoblastic neopalsia[J].Lancet Oncol,2007,8(8):715-724.

共引文献17

同被引文献27

  • 1王璟,庞义存,赵向寨,李萍.妊娠滋养细胞肿瘤78例化疗的疗效[J].中国老年学杂志,2014,34(9):2537-2538. 被引量:4
  • 2李文敏.2种化疗方案治疗绒毛膜癌的经济学评价[J].中国药房,2007,18(23):1769-1770. 被引量:4
  • 3Palmer JE,Hancock BW,Tidy JA.Influence of age as a factor in the outcome of gestational trophoblastic neoplasia[J].J Reprod M ed,2008,53(8):565-574.
  • 4Salehi S,Eloranta S,Johansson AL,et al.Reporting and incidence trends of hydatidiform mole in Sw eden 1973-2004[J].Acta Oncol,2011,50(3):367-372.
  • 5Braun-Parvez L,Charlin E,Caillard S,et al.Gestationalchoriocarcinoma transmission follow ing multiorgan donation[J].Am J Transplant,2010,10(11):2541-2546.
  • 6Chalouhi GE,Golfier F,Soignon P,et al.Methotrexate for2000 FIGO low-risk gestational trophoblastic neoplasia patients:efficacy and toxicity[J].Am J Obstet Gynecol,2009,200(6):643,e1-e6.
  • 7Bianconi MI,Otero S,Moscheni O,et al.Gestational trophoblastic disease:a 21-year review of the clinical experience at an Argentinean public hospital[J].J Reprod M ed,2012,57(7-8):341-349.
  • 8Nagy B,Molnar J,Rovo L,et al.Effective chemoradiotherapy w ithout additive toxicity in locoregionally advanced head and neck cancer[J].Anticancer Res,2003,23(5):4329-4332.
  • 9Feng F,Xiang Y.Surgical management of chemotherapy-resistant gestational trophoblastic neoplasia[J].Expert Rev Anticancer,2010,10(1):71-80.
  • 10Douglas W, Strand D J, DeGraff M, et al. Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration[J]. The American Journal of Pathology ,2013,182(2): 449 - 459.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部